Methods for antagonizing glutamate neurotoxicity
- PMID: 2201346
Methods for antagonizing glutamate neurotoxicity
Abstract
Recent evidence suggests that glutamate-induced neuronal damage may contribute importantly to neuronal death in several neurological diseases, including cerebral hypoxia-ischemia. This review outlines a range of measures that might be used to protect neurons from such excitotoxic damage. The organizing thesis is a speculative consideration of glutamate neurotoxicity as a sequential three-stage process--induction, amplification, and expression--each perhaps specifically amenable to therapeutic interference. Overstimulation of glutamate receptors likely induces the intracellular accumulation of several substances, including Ca2+, Na+, inositol-1,4,5-trisphosphate, and diacylglycerol. Blockade of this induction might be accomplished most easily by antagonizing postsynaptic glutamate receptors, but also might be accomplished by reducing glutamate release from presynaptic terminals, or improving glutamate clearance from synaptic clefts. Following induction, several steps may importantly amplify the resultant rise in intracellular free Ca2+, and promote the spread of excessive excitation to other circuit neurons. Protective strategies operative at this level might include blockade of additional Ca2+ influx, blockade of Ca2+ release from intracellular stores, and interference with the mechanisms coupling glutamate receptor stimulation to lasting enhancements of excitatory synaptic efficacy. Following amplification, toxic levels of intracellular free Ca2+ might trigger destructive cascades bearing direct responsibility for resultant neuronal degeneration--the expression of excitotoxicity. The most important cascades to block may be those related to the activation of catabolic enzymes, and the generation of free radicals. Broad consideration of possible methods for antagonizing glutamate neurotoxicity may be needed to develop therapies with the greatest efficacy, and least adverse consequences for brain function.
Similar articles
-
Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.Mol Pharmacol. 1989 Jul;36(1):106-12. Mol Pharmacol. 1989. PMID: 2568579
-
[Cerebral ischemia-hypoxia and biophysical mechanisms of neurodegeneration and neuroprotection effects].Fiziol Zh (1994). 2003;49(2):7-12. Fiziol Zh (1994). 2003. PMID: 12945108 Review. Ukrainian.
-
Excitatory amino acids and neurotoxicity.Funct Neurol. 1993 Jul-Aug;8(4):279-92. Funct Neurol. 1993. PMID: 8314120 Review.
-
Delayed application of aurintricarboxylic acid reduces glutamate-induced cortical neuronal injury.J Neurosci Res. 1994 May 1;38(1):101-8. doi: 10.1002/jnr.490380113. J Neurosci Res. 1994. PMID: 7914546
-
The chemical biology of clinically tolerated NMDA receptor antagonists.J Neurochem. 2006 Jun;97(6):1611-26. doi: 10.1111/j.1471-4159.2006.03991.x. J Neurochem. 2006. PMID: 16805772 Review.
Cited by
-
Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration.J Biol Chem. 2003 Oct 31;278(44):43508-15. doi: 10.1074/jbc.M307075200. Epub 2003 Aug 13. J Biol Chem. 2003. PMID: 12917400 Free PMC article.
-
Adenosine influences the high-affinity uptake of transmitter glutamate and aspartate under conditions of hepatic encephalopathy.Metab Brain Dis. 1993 Jun;8(2):73-80. doi: 10.1007/BF00996890. Metab Brain Dis. 1993. PMID: 8102777
-
Protection against glutathione depletion-associated oxidative neuronal death by neurotransmitters norepinephrine and dopamine: Protein disulfide isomerase as a mechanistic target for neuroprotection.Acta Pharmacol Sin. 2022 Oct;43(10):2527-2541. doi: 10.1038/s41401-022-00891-w. Epub 2022 Mar 28. Acta Pharmacol Sin. 2022. PMID: 35347247 Free PMC article.
-
Management of acute ischemic stroke. An update for primary care physicians.West J Med. 1997 Apr;166(4):253-62. West J Med. 1997. PMID: 9168683 Free PMC article. Review.
-
Effects of mild hypothermia on the release of regional glutamate and glycine during extended transient focal cerebral ischemia in rats.Neurochem Res. 1998 Jul;23(7):991-6. doi: 10.1023/a:1021088523137. Neurochem Res. 1998. PMID: 9690742
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous